CoChat

Customizing the genome as therapy for the β-hemoglobinopathies.

Open access

The DOI matches its Crossref record; 175 of the 176 references it cites were found in a registry or an index.

Abstract

Despite nearly complete understanding of the genetics of the β-hemoglobinopathies for several decades, definitive treatment options have lagged behind. Recent developments in technologies for facile manipulation of the genome (zinc finger nucleases, transcription activator-like effector nucleases, or clustered regularly interspaced short palindromic repeats–based nucleases) raise prospects for their clinical application. The use of genome-editing technologies in autologous CD34+ hematopoietic stem and progenitor cells represents a promising therapeutic avenue for the β-globin disorders. Genetic correction strategies relying on the homology-directed repair pathway may repair genetic defects, whereas genetic disruption strategies relying on the nonhomologous end joining pathway may induce compensatory fetal hemoglobin expression. Harnessing the power of genome editing may usher in a second-generation form of gene therapy for the β-globin disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2016-01-678128

Cites

175 of 175 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 175 references

Cited by

See all 61

Metadata

Authors
Canver, M. C., & Orkin, S. H.
Affiliations
Boston Children's Hospital (US)
Venue
Blood
Published
2016-05-26
Volume
127
Issue
21
Pages
2536-2545
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2323549005
Cited by
61
References
176
Citations by year
2026: 6 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 8 · 2019: 7 · 2018: 10 · 2017: 9 · 2016: 6
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (P01HL032262, R01HL032259)
  • National Institute of Diabetes and Digestive and Kidney Diseases (F30DK103359)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
β-hemoglobinopathies, genome editing, zinc finger nucleases, TALEN, CRISPR/Cas9, autologous hematopoietic stem cells, CD34+ cells, homology-directed repair, non-homologous end joining, fetal hemoglobin, sickle cell disease, gene therapy
MeSH terms
Gene Editing, Animals, Hemoglobinopathies, Humans, Hematopoietic Stem Cell Transplantation, Targeted Gene Repair, Autografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Customizing the genome as therapy for the β-hemoglobinopathies. https://app.cochat.ai/papers/10.1182/blood-2016-01-678128
The paper
Canver, M. C., & Orkin, S. H. (2016). Customizing the genome as therapy for the β-hemoglobinopathies. Blood. https://doi.org/10.1182/blood-2016-01-678128

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.